ABOUT US TEAM PLATFORMS PRODUCTS NEWS JOIN OUR TEAM SHERLOCK Biosciences in the News. Press Release Sherlock Biosciences Named to Fast Company’s First-Ever List of the Next Big Things in Tech LEARN MORE NEWS OVERVIEW Read about Sherlock’s work to revolutionize molecular diagnostics and bring highly accurate, rapid, and affordable testing to the world. Media Inquiries press@sherlock.bio Press Releases Publications Sherlock in the News Webinars and Events Videos November 18, 2021 Sherlock Biosciences Named to Fast Company’s First-Ever List of the Next Big Things in Tech July 12, 2021 Sherlock Biosciences Announces Appointment of Bryan Dechairo as President and Chief Executive Officer June 22, 2021 Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up To 10 Million Tests Per Month June 14, 2021 The 221b Foundation Grants License to ALBOT Technologies to Develop, Manufacture and Distribute CRISPR COVID-19 Diagnostic Kits in India June 02, 2021 Sherlock Biosciences Announces Initial Results of Automation Study with NorDx Laboratories on CRISPR-based Test for SARS-CoV-2 May 11, 2021 The 221b Foundation Grants License to Rokline Health Concepts, LLC to Develop and Manufacture CRISPR COVID-19 Diagnostic Kits May 04, 2021 Sherlock Biosciences’ CRISPR SARS-Cov-2 Test Selected As Finalist In “On The Rise” And Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards May 03, 2021 The 221b Foundation and LogicInk Announce License Agreement to Utilize Sherlock Biosciences’ CRISPR Technology to Develop Instrument-free Diagnostic for COVID-19 April 21, 2021 The 221b Foundation Grants Licenses to Multiple Organizations to Develop and Distribute CRISPR COVID-19 Diagnostic Kits Globally March 09, 2021 Sherlock Biosciences Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021 January 06, 2021 The 221b Foundation Establishes Coalition to Control the Spread of COVID-19 in Nepal December 16, 2020 Sherlock Biosciences Receives $5 Million Grant to Advance INSPECTR™ Platform for COVID-19 Self-test December 07, 2020 Sherlock Biosciences Announces Discovery of Novel CRISPR-Cas Enzymes, Enabling Simple Multiplex Diagnostic Solutions December 04, 2020 Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo Biotech November 20, 2020 Sherlock Biosciences Chosen as a 2020 Red Herring Top 100 North America Winner September 15, 2020 Sherlock Biosciences Launches The 221b Foundation to Address the COVID-19 Pandemic and Equity in STEM September 09, 2020 Sherlock Biosciences Appoints Dr. Martin Madaus as Chief Operations Officer September 01, 2020 Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit August 12, 2020 Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2 July 01, 2020 Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19 June 16, 2020 Sherlock Biosciences Named Technology Pioneer by World Economic Forum June 08, 2020 Sherlock Biosciences and Integrated DNA Technologies (IDT) Announce Strategic Partnership for Manufacturing CRISPR SARS-CoV-2 Diagnostic and Research Products May 21, 2020 Sherlock Biosciences Launches Innovation Lab to Develop COVID-19 Diagnostics with $7.5 Million Grant from Open Philanthropy May 07, 2020 Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic March 09, 2020 Sherlock Biosciences Named “Fierce 15” Company by FierceMedTech February 28, 2020 Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology December 02, 2019 Sherlock Biosciences Announces Two Upcoming December Conferences October 29, 2019 Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic Tests September 26, 2019 Sherlock Biosciences Awarded Contract from U.S. Defense Threat Reduction Agency to Support the Development of Ultra-Fast, Ultra-Sensitive Diagnostics July 29, 2019 Sherlock Biosciences Strengthens Leadership Team with Appointments of William J. Blake, Ph.D., as Chief Technology Officer and Don Haut, Ph.D., as Chief Business Officer April 23, 2019 Sherlock Biosciences Announces Close of Series A Round with Additional Investment Led by Northpond Ventures and Baidu Ventures March 21, 2019 Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering Biology Contact us to learn more about how we are engineering biology to test anywhere, everywhere. 617-612-8209 info@sherlock.bio Sherlock Biosciences 40 Guest Street, 3rd Floor Boston, MA 02135 © 2021 Sherlock Biosciences. All Rights Reserved. Sherlock uses your contact information to update you about Sherlock’s products and services. To learn more about how Sherlock treats your information, please review our privacy policy. Terms of Sale. We use cookies and by using this site or closing this message, you agree to our privacy policy. Allow Scroll to close this message.